Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for 4018.SR and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for 4018.SR and 80,000+ other tickers.
See exactly how 4018.SR's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 4018.SR and 80,000+ other tickers.
Almoosa Health Company functions as a private healthcare provider situated in Saudi Arabia. The firm engages in storing medical goods and distributing pharmaceuticals, beauty products, and single-use medical supplies. Additionally, it oversees the operation of hospitals and pharmacies, offering a comprehensive suite of services that includes critical care, active rehabilitation, extended care, in-home healthcare assistance, and health-related educational programs. Founded in 1996, the company is headquartered in Al Mubarraz, Saudi Arabia, and operates as a subsidiary of Abdulaziz bin Abdullah Almoosa Investment Company.
No recent news available.